SPATA2L antibody
Principal name
SPATA2L antibody
Alternative names for SPATA2L antibody
Spermatogenesis-associated protein 2-like, SPATA2-like protein
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of SPATA2L antibody
- Kit Component:
- - KN208075G1, SPATA2L gRNA vector 1 in pCas-Guide vector
- KN208075G2, SPATA2L gRNA vector 2 in pCas-Guide vector
- KN208075D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Strausberg,R.L., (2002) Proc. Natl. Acad. Sci. U.S.A. 99 (26), 16899-16903
Human Brain; WB Suggested Anti-SPATA2L Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Human brain; SPATA2L antibody - middle region (ARP52903_P050) in Human Brain cells using Western Blot
Western blot analysis in MCF-7 cell line lysates (35ug/lane) using SPATA2L antibody Cat.-No. AP54002PU-N. This demonstrates the SPATA2L antibody detected the SPATA2L protein (arrow).
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SPATA2L (RC208075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SPATA2L.
Immunohistochemical staining of paraffin-embedded Carcinoma of Human pancreas tissue using anti-SPATA2L mouse monoclonal antibody. (TA802363) Dilution: 1:150
Immunohistochemical staining of paraffin-embedded Human pancreas tissue within the normal limits using anti-SPATA2L mouse monoclonal antibody. (TA802363) Dilution: 1:150
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SPATA2L (RC208075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SPATA2L.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SPATA2L (RC208075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SPATA2L.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SPATA2L (RC208075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SPATA2L.
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-SPATA2L mouse monoclonal antibody. (TA802368) Dilution: 1:150
Immunohistochemical staining of paraffin-embedded Human tonsil within the normal limits using anti-SPATA2L mouse monoclonal antibody. (TA802368) Dilution: 1:150
Immunohistochemical staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-SPATA2L mouse monoclonal antibody. (TA802368) Dilution: 1:150
Immunohistochemical staining of paraffin-embedded Human lymph node tissue within the normal limits using anti-SPATA2L mouse monoclonal antibody. (TA802368) Dilution: 1:150
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SPATA2L (RC208075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SPATA2L.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SPATA2L (RC208075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SPATA2L.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SPATA2L (RC208075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SPATA2L.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SPATA2L (RC208075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SPATA2L.
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA802368 | SPATA2L antibody |
||||||
| SPATA2L mouse monoclonal antibody, clone OTI3F6 (formerly 3F6) | |||||||
 |
Mouse | IgG2a | OTI3F6 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +4 additional images |
Highly validated antibody!
|
||||||
| TA802355 | SPATA2L antibody |
||||||
| SPATA2L mouse monoclonal antibody, clone OTI1E5 (formerly 1E5) | |||||||
 |
Mouse | IgG2b | OTI1E5 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA802363 | SPATA2L antibody |
||||||
| SPATA2L mouse monoclonal antibody, clone OTIH8 (formerly H8) | |||||||
 |
Mouse | IgG2b | OTIH8 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| +2 additional images |
|
||||||
| TA802364 | SPATA2L antibody |
||||||
| SPATA2L mouse monoclonal antibody, clone OTI3E5 (formerly 3E5) | |||||||
 |
Mouse | IgG1 | OTI3E5 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA802365 | SPATA2L antibody |
||||||
| SPATA2L mouse monoclonal antibody, clone OTI4F3 (formerly 4F3) | |||||||
 |
Mouse | IgG1 | OTI4F3 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA802370 | SPATA2L antibody |
||||||
| SPATA2L mouse monoclonal antibody, clone OTI2B4 (formerly 2B4) | |||||||
 |
Mouse | IgG1 | OTI2B4 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA802374 | SPATA2L antibody |
||||||
| SPATA2L mouse monoclonal antibody, clone OTI2D8 | |||||||
 |
Mouse | IgG1 | OTI2D8 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| TA802375 | SPATA2L antibody |
||||||
| SPATA2L mouse monoclonal antibody, clone OTI2E2 (formerly 2E2) | |||||||
 |
Mouse | IgG1 | OTI2E2 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| AP54002PU-N | SPATA2L (Center) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP308075 | SPATA2L |
||||
| Recombinant protein of human spermatogenesis associated 2-like (SPATA2L) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY407590 | SPATA2L overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR220728L2V | Lenti ORF particles, Spata2l (GFP-tagged) - Mouse spermatogenesis associated 2-like (Spata2L), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR220728L1V | Lenti ORF particles, Spata2l (Myc-DDK-tagged) - Mouse spermatogenesis associated 2-like (Spata2L), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||